The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19

Clinical trial NCT04629157 · COMPLETED

Trial details

NCT number: NCT04629157
Sponsor: Alder Hey Children's NHS Foundation Trust
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

This is a Pilot Study Which Aims to Assess the Validity and Applicability of Lateral Flow Assays (LFAs) Which Can be Used as a Point of Care Test for COVID-19 Covid19

Start date: 2020-11-05
Primary completion: 2021-02-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.